MMJ PhytoTech Ltd (ASX:MMJ) Investment in Embark Health
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) has invested CAD$0.15m for a 2.5% shareholding in privately-held Embark Health Inc as part of their CAD$1m seed funding round.
Companies in the News
Medical Equipment
MMJ PhytoTech Ltd (ASX:MMJ) United Greeneries MOU to Supply Recreational Cannabis
MMJ PhytoTech Limited (ASX:MMJ) is pleased to note the attached news release by Harvest One Cannabis Inc. (CVE:HVT) confirming a Memorandum of Understanding ("MOU") between its wholly-owned subsidiary United Greeneries and the British Columbia Liquor Distribution Board for the supply of recreational cannabis.
The Hydroponics Company Ltd (ASX:THC) Acquisition Delivers +$16m to Balance Sheet & Medicinal Cannabis Strategy
The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading Medicinal Cannabis company, provides the following update with respect to a revaluation of the Company's Southport pharmaceutical manufacturing facility of $14.58 million with an unmatched domestic manufacturing capability.
The Hydroponics Company Ltd (ASX:THC) Appoints CEO and Strong, Experienced Medicinal Cannabis Leadership Team
The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading Medicinal Cannabis company, after an extensive executive search, has appointed Ken Charteris as Group Chief Executive Officer, effective 11 July 2018.
The Hydroponics Company Ltd (ASX:THC) Executes Initial Cooperation Agreement with Endoca
The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading Medicinal Cannabis Company has signed a binding Letter of Intent with Endoca BV.
The Hydroponics Company Ltd (ASX:THC) North American Update
The Hydroponics Company Limited (ASX:THC), Australia's leading medicinal cannabis company1, provides the following update with respect to the Company's North American development plans.
The Hydroponics Company Ltd (ASX:THC) Cannabis Strains Exchange with Canadian Licensed Producer
The Hydroponics Company Limited (ASX:THC) is pleased to advise THC Pharma Pty Ltd, a wholly owned subsidiary of THC, has concluded a Letter of Intent with Ascent Industries Corp.
◂Previous Page
Medical Equipment Next Page▸
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Central Petroleum Limited (ASX:CTP) Strategic Expansion Into the Cooper and Otway Basins
- Beetaloo Energy Australia Limited (ASX:BTL) Carpentaria-5H Flow Testing Update
- Central Petroleum Limited (ASX:CTP) Sub-Salt Exploration Permit Sale Update
- Basin Energy Ltd (ASX:BSN) Completes Phase One Drilling and Expands Sybella-Barkly
- Deep Yellow Limited (ASX:DYL) Tumas Project Update
- Central Petroleum Limited (ASX:CTP) LOI Signed for New Drilling and Long-Term Gas Supply
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) US Patent Secured for PromarkerEso Diagnostic Test for Throat Cancer
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Changes How Doctors Manage Diabetic Kidney Disease - Study Published
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Predicts Risk of DKD in Aboriginal Australians
- TempraMed Technologies Ltd. (CNSX:VIVI) Exclusive Commercial Distribution Agreement with Turkish Medical Device Supplier
- BPH Energy Limited (ASX:BPH) Chair's Address to Shareholders
- Proteomics International Laboratories Ltd (ASX:PIQ) US Medicare Sets Reimbursement Price for PromarkerD DKD Test
Social Media
